The estimated Net Worth of Anthony A. Jr. Florence is at least $234 Million dollars as of 17 July 2023. Mr. Florence owns over 333,333 units of Casper Sleep Inc stock worth over $165,915,170 and over the last 10 years he sold CSPR stock worth over $68,251,050. In addition, he makes $0 as Independent Director at Casper Sleep Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Florence CSPR stock SEC Form 4 insiders trading
Anthony has made over 55 trades of the Casper Sleep Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 333,333 units of CSPR stock worth $999,999 on 17 July 2023.
The largest trade he's ever made was buying 15,000,000 units of Casper Sleep Inc stock on 7 September 2018 worth over $25,050,000. On average, Anthony trades about 1,438,526 units every 36 days since 2015. As of 17 July 2023 he still owns at least 24,471,264 units of Casper Sleep Inc stock.
You can see the complete history of Mr. Florence stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Anthony Florence biography
Anthony Florence serves as Independent Director of the Company. Mr. Florence is a General Partner and head of the technology investing practice at New Enterprise Associates, Inc., or NEA, a venture capital firm he joined in 2008. Prior to joining NEA, Mr. Florence was a Managing Director at Morgan Stanley & Co. LLC, where he served as Head of East Coast Technology Banking in New York and as a member of the North American Management Committee for Investment Banking. From October 2010 until November 2017, Mr. Florence served on the board of directors of Care.com, the largest online marketplace for finding and managing family care. He also served on the board of directors of Cvent, Inc., a meetings, events and hospitality technology provider, from July 2011 until November 2016 and currently serves as a director of several private companies. Mr. Florence received an M.B.A. from the Tuck School of Business at Dartmouth and an A.B. in Economics from Dartmouth College.
How old is Anthony Florence?
Anthony Florence is 50, he's been the Independent Director of Casper Sleep Inc since 2014. There are 4 older and 14 younger executives at Casper Sleep Inc. The oldest executive at Casper Sleep Inc is Stephen M. Riddell, 65, who is the Head of Customer Experience.
What's Anthony Florence's mailing address?
Anthony's mailing address filed with the SEC is 5425 Wisconsin Ave #800, Chevy Chase, MD 20815, USA.
Insiders trading at Casper Sleep Inc
Over the last 5 years, insiders at Casper Sleep Inc have traded over $2,105,135 worth of Casper Sleep Inc stock and bought 2,546,666 units worth $30,471,492 . The most active insiders traders include Anthony A. Jr. Florence, Enterprise Associates 14, L... und Gregory J Macfarlane. On average, Casper Sleep Inc executives and independent directors trade stock every 32 days with the average trade being worth of $1,084,617. The most recent stock trade was executed by Michael P. Monahan on 14 September 2021, trading 10,956 units of CSPR stock currently worth $56,971.
What does Casper Sleep Inc do?
About Casper
Casper believes everyone should sleep better. The Sleep Company has a full portfolio of obsessively engineered sleep products-including mattresses, pillows, bedding, and furniture-designed in-house by the Company's award-winning R&D team at Casper Labs in San Francisco. In addition to its e-commerce business, Casper owns and operates 59 Sleep Shops across North America and its products are available at a growing list of retailers.
What does Casper Sleep Inc's logo look like?
Complete history of Mr. Florence stock trades at Adaptimmune Therapeutics Plc, Appian Corp, ARCA biopharma Inc, Ardelyx Inc, AVEO Pharmaceuticals Inc, Cerecor Inc, Genocea Biosciences Inc, Regulus Therapeutics Inc, Savara Inc, TRACON Pharmaceuticals Inc, Mersana Therapeutics Inc, Synlogic Inc, Surface Oncology Inc, Mirum Pharmaceuticals Inc, Casper Sleep Inc, Trevi Therapeutics, Marker Therapeutics, Akouos, Inozyme Pharma, Metacrine, Eargo, Bright Health und Robinhood Markets, Class A Common Stock
Casper Sleep Inc executives and stock owners
Casper Sleep Inc executives and other stock owners filed with the SEC include:
-
Emilie Arel,
President, Chief Commercial Officer, Interim Principal operating officer -
Neil Parikh,
Chief Strategy Officer, Director -
Emilie Arel,
Pres & CEO -
Philip A. Krim,
Co-ÂFounder & Non-Exec. Chairman -
Dani Reiss,
Independent Director -
Michael P. Monahan,
Chief Financial Officer -
Diane Irvine,
Independent Director -
Philip Krim,
Chairman of the Board, Chief Executive Officer -
Jack Lazar,
Independent Director -
Karen Katz,
Lead Independent Director -
Benjamin Lerer,
Independent Director -
Anthony Florence,
Independent Director -
Jeffery Chapin,
Chief Product Officer -
Jonathan Truppman,
General Counsel, Secretary -
Elizabeth Wolfson,
Chief People Officer -
Michael Monahan,
Chief Financial Officer -
Jason I. Costi,
VP of Fin. -
Stephen M. Riddell,
Head of Customer Experience -
Timothy Luke Sherwin,
Chief Creative Officer -
Dara Williams,
Chief People & Diversity Officer -
Lindsay Kaplan,
VP of Communications -
Jonathan Truppman,
Gen. Counsel & Sec. -
Jeffrey R. Chapin,
Co-Founder & Advisor -
Enterprise Associates 14, L...,
-
Enterprise Associates 14, L...,
-
Gregory J Macfarlane,
CFO & COO